Medical release archive

Evusheld long-acting antibody combination retains neutralising activity against Omicron variants BA.4 and BA.5, according to new study from University of Oxford

New nirsevimab data analyses reinforce efficacy against RSV

SABINA programme demonstrates SABA reliever overuse is a global issue in asthma management

Evusheld long-acting antibody combination retains neutralising activity against Omicron variants including BA.2 in new independent studies

New data further reinforce efficacy of Tezspire in a broad population of severe asthma patients

Eplontersen granted Orphan Drug Designation in the US for transthyretin amyloidosis

Lokelma granted Fast Track Designation in the US to reduce cardiovascular outcomes in patients on chronic haemodialysis with hyperkalaemia

New sub-analyses further support consistency of Farxiga’s cardiorenal and mortality benefits in treating chronic kidney disease

Fasenra granted Orphan Drug and Fast Track Designations in the US for eosinophilic gastritis and eosinophilic gastroenteritis

Saphnelo consistently reduces systemic lupus erythematosus disease activity regardless of disease duration and prior treatment